Skip to main content

Table 2 Detailed patient, tumor, treatment characteristics and outcomes

From: Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy

PatientAgeGenderCell typeAJCC stagelateralitySurgery typeMarginPNILVSIAdjuvant treatmentPost treatment statusTime to local progression (months)Time to distant metastasis (months)Metastasis siteTotal follow up time (months)Final status
145FemaleCEPAcT1aN0M0LExcision+RT aloneCR 161alive
220FemaleACCcT2aN0M0Lexcision+RT aloneCR 28dead
358FemaleACCcT2aN0M0Lexcision+RT aloneCR 20alive
455MaleCEPAcT2aN0M0Rexcision++RT aloneCR 39alive
577MaleCEPAcT2aN0M0Rexcision+RT aloneCR 26alive
653FemaleCEPAcT2aN0M0Lexcision++RT alone (proton)CR 5alive
745MaleACCcT2bN0M0Lexcision+CCRT (proton + photon)CR 14alive
835MaleACCcT2cN0M0Lexcision+++RT aloneCR 158alive
943FemaleACCcT2cN0M0Rexcision++RT aloneCR26mediastinal LNs, liver, bone, lungs26dead with disease
1053FemaleACCcT2cN0M0Rexcision+++RT aloneCR 40alive
1185MaleACCcT3cN0M0Lneedle biopsyRT alonePR1034lungs43alive with disease
1262MaleCEPAcT3cN0M0Lexcision++RT aloneCR5051lungs92dead with disease
1380MaleCEPAcT3cN0M0Rneedle biopsyRT aloneCR 17dead
1436FemaleACCcT4bN0M0Lexcision++RT aloneCR106liver16dead with disease
1530FemaleACCcT4bN0M0Lexcision++RT aloneCR510bone and lungs28dead with disease
1658FemaleCEPAcT4bN0M0Rexcision+++RT aloneCR65parotid, neck nodes, lungs12dead with disease
1760MalePD adenocT4cN0M0Lneedle biopsyCCRTPR5bone20dead with disease
1871FemalePD adenocT4cN0M0Rexcision+CCRTCR5liver and bone15dead with disease
  1. AJCC the American Joint Committee on Cancer, PNI perineural invasion, LVSI lymphovascular invasion, ACC adenoid cystic carcinoma, CEPA carcinoma ex pleomorphic adenoma, PD adeno poorly differentiated adenocarcinoma, L left, R right, RT radiotherapy, CCRT concurrent chemoradiotherapy, CR=, LN lymph node.